Gong tells you "price was mentioned." Zime tells you whether the pain is a must-have, whether your rep mapped the right product to the right use case, and whether this deal will actually close — scored based on what is critical to win your deals, not static prompts.
Pipeline risks flagged before the forecast call, not during it
Less manager time on manual call review — red alerts surface automatically
Qualification accuracy on budget and pain — verified against thresholds, not just mentioned
More deals rescued per quarter because risks are caught before they go dark
Managers walk into pipeline reviews with three tabs open, rep narratives in their heads, and CRM fields that haven't been updated since last Friday. They spend 40 minutes on ten deals asking "what's happening with this one?" — and leave without knowing which deals need intervention, or why. The tools that were supposed to fix this — Gong, Clari, Chorus — gave managers more to look at. They didn't give them less to figure out.
"Today what the way I go about it is I go into HubSpot, I go into a rep and then their pipeline. Then I look at which account and then I go and see their email change and all of that. So I'm getting insight but I'm not getting right away to it. I have to go through those three, four steps."
Ranjan R Reddy, CEO, Bureau — before Zime
CRM data is stale and missing deal context
Reps don't update CRM between calls. Pipeline reviews become interrogation sessions — managers ask "what's going on with this deal?" instead of coaching. One leader described their CRM as "majorly outdated," only getting updated when deals moved stages.
Alerts based on mentions, not qualification
Gong flags "budget mentioned." That's not the same as "budget verified above the required threshold." "Pain discussed" is not the same as "pain is urgent enough to drive a buying decision." Mentions are not qualification.
No marching orders in the alerts
Current tools don't know your qualification thresholds, your stage exit criteria, or your winning nuances. A customer says their pain is compliance visibility. The rep demos workflow automation. Generic AI marks the demo complete. Zime flags the mismatch.
Managers diagnose manually — every time
When tools surface raw signals without deal judgment, managers still have to listen to calls, interview reps, or manually compare each deal against the playbook. They aren't coaching — they're reconstructing.
The failure mode is no longer "we don't have enough data." It's "we have signals, but not the deal judgment to know which ones matter." Related: Why your CRM can't tell you what's actually happening in deals →
Gong alternatives for contextual pipeline review · How Zime compares to Clari for deal risk
MEDDPIC is a qualification framework. It's not a stage completion table. What matters at Discovery is different from what matters in a POC. Zime scores each deal against the criteria that are actually relevant to where it is in your process — built from your own winning deals. Gong applies the same tick sheet at every stage. Zime doesn't.
| Stage | What Zime checks (beyond MEDDPIC) | What Gong and Clari miss |
|---|---|---|
| Stage 1 Qualification | Is the pain a must-have or a nice-to-have? Is the ICP confirmed? Did the rep map the right product to the customer's actual use case? | Checks whether pain keywords were mentioned — not whether the pain is critical enough to drive a buying decision |
| Stage 2 Discovery | Did the rep ask second and third order questions? Was technical context captured? Did urgency surface — or was it assumed? | No discovery quality scoring. Transcript summary only. No evaluation of which questions were asked or skipped |
| Stage 3 Opportunity | Business impact quantified above threshold? Champion confirmed? Decision criteria mapped to your product's capabilities? | Can flag whether "budget" or "decision maker" was mentioned — not whether they're genuinely confirmed and engaged |
| Stage 4 POC | POC success criteria agreed in writing? Technical requirements clear? Is the rep solving the pain the customer actually named? | No POC-specific criteria. All stages get the same MEDDPIC tick sheet regardless of where the deal actually is |
| Stage 5 Negotiation | Multithreaded to economic buyer? Competitive displacement brief ready? Champion armed with what they need to close procurement? | Can note that price discussions occurred — not whether the champion has what they need to get internal buy-in before the deal slips |
"This is industry first. AI so far has been a visibility tool. What AI here is an execution tool. You can drive the execution, objection handling… in the flow of work."
Lalit Kumar, Versa Networks — on Zime's pipeline review and execution layer
Skan AI sells across multiple use cases, stakeholders, and global competitive cycles where implementation complexity is a real buyer concern. As Aman Rangrass put it: "Often a question of like where do I get this information from? It probably exists somewhere in the company. Someone just has to streamline it."
Before Zime, pipeline reviews depended on reps reconstructing context from memory. Leaders navigated account, pipeline, email thread, and call notes in HubSpot before reaching insight. Reps captured the pain directly: "I hate HubSpot. I don't want to go near it." and "It took me minimum like 40 seconds per contact to do it manually… this is gonna take me 4 hours."
With Zime, pipeline reviews became a working leadership habit instead of a chasing exercise. Deal context surfaced automatically, call summaries replaced rep narratives, and Aman shared sales intelligence across functions: "What I love is how the sales intelligence is laid out. I send it to everyone — product marketing, my team — and it's super easy for them to just go to their section and dive in."
The adoption signal became clear: "I think everything you've shown me so far is super. At least as a user, I'm using it actively, which is the most important piece." Aman then proactively scheduled team enablement in his weekly Friday meeting.
MyAdvice sells websites, marketing, patient acquisition, and practice growth services in competitive cycles. Chad Erickson described the reality: "Even though it's a wow, aha, this is great… they still might feel like they have to perform their due diligence and compare us with one of our competitors."
The challenge was not activity volume. It was coaching visibility. Chad could see stage strengths by rep, but not the why from existing tools. HubSpot had data, yet forecast calls still depended on rep judgment and manual call inspection.
With Zime, pipeline reviews became coaching sessions built on evidence. Chad could see objections, engagement signals, and deal context in one place: "It's very helpful for me to be able to see everything here and have conversations with my guys about these."
Weekly pipeline alerts became part of operating rhythm: "Yeah, I do. Actually, this is helpful. This is awesome… I was actually really excited. I got that email this morning."
Bureau sells across identity, fraud, verification, device intelligence, and transaction monitoring. Every review used to be a research exercise. Ranjan described the flow: "I go into HubSpot, I go into a rep and then their pipeline… I have to go through those three, four steps."
The stack stored data but did not make it actionable for weekly reviews. Senior leader judgment existed, but did not scale to every manager. Zime reframed the issue: the tool can do the RCA and tell a manager what to inspect before the review.
With Zime, pipeline reviews shifted to stage-wise evidence: likelihood, qualification gaps, open objections, and next actions. Managers got deal-level clarity before check-ins. RevOps also saw HubSpot notes auto-created and immediately asked for property-level pushes.
"You can come to any deal… open this before your weekly check-ins… and it gives you exactly what you need to talk to your reps to move this deal to the next stage."
| Capability | Gong | Clari | Chorus | Zime |
|---|---|---|---|---|
| Scores pain as must-have vs. nice-to-have | ✕ | ✕ | ✕ | ✓ |
| Verifies budget above a threshold — not just "mentioned" | ✕ | ✕ | ✕ | ✓ |
| Detects customer-rep use case mismatch | ✕ | ✕ | ✕ | ✓ |
| Stage-specific exit criteria (not one tick sheet for all stages) | ✕ | Partial | ✕ | ✓ |
| Built from your winning deals — not generic methodology | ✕ | ✕ | ✕ | ✓ |
| Flags pipeline risk before the forecast call | Partial | Partial | ✕ | 80%+ |
| Surfaces next 3 manager actions per deal | ✕ | ✕ | ✕ | ✓ |
| Custom to your products, stages, and GTM motion | ✕ | ✕ | ✕ | ✓ |
Gong alternatives for pipeline intelligence · Clari alternatives for deal risk and forecasting
30 minutes. Three things you'll walk away with.
Book a 30-minute session. We'll run a live pipeline review on your real deals — no slides, no generic demo. Your deals, your stages, your context.
